Tech Company Financing Transactions
Chromatin Funding Round
On 11/3/2008, Chromatin raised $12.4 million in Series C funding from Burrill & Company and Unilever.
Transaction Overview
Company Name
Announced On
11/3/2008
Transaction Type
Venture Equity
Amount
$12,400,000
Round
Series C
Investors
Burrill & Company (John Hamer)
Proceeds Purpose
This investment will support the development of proprietary feedstocks that contain the gene stacks needed to improve yields and reduce the costs of producing fermentable sugars. The company plans to launch strategic partnerships with industry leaders to provide distribution channels for its bioenergy products.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10 South La Salle St. 2100
Chicago, IL 60603
USA
Chicago, IL 60603
USA
Phone
Website
Email Address
Overview
Chromatin, Inc. is focused on developing sorghum, both for traditional agriculture and for uses in new applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daphne Preuss
VP - Bus. Development
Michael Battin
VP - Bus. Development
Charles Miller
VP - Operations
Larry McDowell
VP - R & D
Scott Staggenborg
Browse more venture capital transactions:
Prev: 11/3/2008: Palo Alto Networks venture capital transaction
Next: 11/3/2008: Napera Networks Management venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs